Tracking Nifty 50 Index
Insufficient Data
Less expense ratio implies better returns over the long term
ETF has been able to closely match its benchmark's returns
ETF has not been able to generate better price return than bank FD
Insufficient Data
Unlock exclusive stocks’ data & unlimited access with Tickertape Pro
7 hours ago•The Hindu Businessline
8 hours ago•Economic Times
9 hours ago•Economic Times
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated July 26, 2024, titled "Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 U.S. FDA Approves LEQSELVI (deuruxolitinib)". | Download
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated July 26, 2024, titled "Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 U.S. FDA Approves LEQSELVI (deuruxolitinib)". | Download
Final • Div/Share: ₹ 15
NAVThe net asset value (NAV) of an ETF is based on the current prices of the stocks/assets in the fund and an actual accounting of the total cash in the fund at the time of calculation. Market price can be different from real time NAV due to late market activity and both tend to converge periodically. A market price close to real time NAV is much better for investment!
Insufficient Data